Skip to Content

    Enterprise software company ­Veeva has become an indispensable nucleus for the life sciences industry, helping Big Pharma manage customer databases, track drug developments, and organize clinical trials. Revenues rose by 33% last year to $544 million, as the likes of Abbott, Merck, and Pfizer employed a suite of its cloud-based offerings. Vault, its new content management system, is already being used by 35 of the top 50 pharma companies. The platform could help Veeva take a bigger chunk of the global life sciences applications market, forecast to reach $6.8 billion in sales by 2020.

    Fortune Data StoreLooking for leads, investment insights, or competitive intelligence?Get Premium Access

    Company Information

    Overall Score4.5
    Sector
    Technology
    Industry
    Computer Software
    CEO
    Peter P. Gassner
    Websitehttp://www.veeva.com
    Employees1,794
    HQ Location
    Pleasanton, Calif.
    Revenues ($M) (Past 12 Months)$617
    Profits ($M) (Past 12 Months)$117
    Market Value as of Oct. 9, 2017 ($M)$8,170